PBPH is passively managed, providing targeted exposure to pure-play companies in the pharmaceutical and/or biotechnology industries from the developed markets. The fund follows BITAs thematic methodology, selecting companies that derive at least 50% of their revenue from healthcare-related discovery, development, and therapeutics. Eligible securities must operate within one or more core healthcare sub-themes, including precision medicine & genetic diagnostics, pharmaceutical research & manufacturing, and biotechnology-based therapeutics. The portfolio typically holds 5080 constituents, weighted by free-float market capitalization. The index is reconstituted and rebalanced quarterly.
公司网站 :
https://portfoliobuildingblocketfs.com/pbph/
总经理:-
建立时间:2025
公司总部:Portfolio Building Block World Pharma and Biotech Index ETF
领域:Miscellaneous
行业:Investment trusts/Mutual funds